Manuscripts
Showing 1572 manuscripts.
Live-attenuated respiratory syncytial virus vaccine with M2-2 deletion and with SH non-coding region is highly immunogenic in children
Citation
Petronella Muresan, Peter L.Collins, Coleen K. Cunningham, Ursula J. Buchholz, Charlotte Perlowski, Jennifer Libous, Jennifer Oliva, Patrick Jean-Philippe, Jack Moye Jr, Elizabeth Schappell, Emily Barr, Vivian Rexroad, Laura Fearn, Mikhaela Cielo, Andrew Wiznia, Jaime G. Deville, Elizabeth J. McFarland, Lijuan Yang, Ruth A. Karron, Cindy Luongo. Live-attenuated respiratory syncytial virus vaccine with M2-2 deletion and with SH non-coding region is highly immunogenic in children. Journal of Infectious Diseases. 2020. 221: 2050-2059. PMID: 32006006Year
          2020      
Journal
          Journal of Infectious Diseases      
Study
          IMPAACT 2013      
Alendronate Improves Bone Mineral Density in Children and Adolescents Perinatally Infected With Human Immunodeficiency Virus With Low Bone Mineral Density for Age
Citation
Catherine Gordon, Rohan Hazra, Hans Spiegel, Flavia Ferreira, Fabiana R Amaral, Jesica Pagano-Therrien, Aditya Gaur, Kathy George, jane Benson, George K Siberry, Denise L Jacobson, Jane C Lindsey. Alendronate Improves Bone Mineral Density in Children and Adolescents Perinatally Infected With Human Immunodeficiency Virus With Low Bone Mineral Density for Age. Clinical Infectious Diseases. 2020. 71: 1281-1288. PMID: 31573608Year
          2020      
Journal
          Clinical Infectious Diseases      
Study
          P1076      
Decreased growth among antiretroviral drug and HIV-exposed uninfected versus unexposed children in Malawi and Uganda
Citation
Lillian Wambuzi Ogwang, Rachel Kawalazira, Alex Mutebe, Itziar Familiar-Lopez, MacPherson Mallewa, Taha Taha, Michael J Boivin, Mary Glenn Fowler, Jim Aizire, Alla Sikorskii, PROMISE NEURODEV Study Team. Decreased growth among antiretroviral drug and HIV-exposed uninfected versus unexposed children in Malawi and Uganda. AIDS. 2020. 34: 215-225. PMID: 31634154Year
          2020      
Journal
          AIDS      
Study
          1077BF      
Predictors of Viremia in Postpartum Women on Antiretroviral Therapy
Citation
K Rivet Amico, Jose Pilotto, Gaerolwe Masheto, Jullapong Achalapong, Elizabeth Machado, Kulkanya Chokephaibulkit, Geraldo Duarte, Esau Joao, Kathleen K Graham, Katherine M Knapp, Alice M Stek, Gwendolyn B Scott, Anne Coletti, Amy J Loftis, Risa M Hoffman, Nahida Chakhtoura, Meredith G Warshaw, Judith S Currier, PROMISE 1077HS Team. Predictors of Viremia in Postpartum Women on Antiretroviral Therapy. Journal of Acquired Immune Deficiency Syndromes. 2020. 83: 72-80. PMID: 31651545Year
          2020      
Journal
          Journal of Acquired Immune Deficiency Syndromes      
Study
          1077HS      
Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn Infants
Citation
RL Morrison, B Lin, EV Capparelli, RT Bailer, JT Safrit, JR Mascola, LM Mofenson, BS Graham, B Mathieson, IMPAACT P1112 team, ME Valentine, C Perlowski, B Smith, R Hazra, L Purdue, P Muresan, PA Harding, T Mbengeranwa, LG Robinson, CK Cunningham, A Wiznia, EJ McFarland, G Theron. Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn Infants. Journal of Infectious Diseases. 2020. 222: 628-636. PMID: 31681963Year
          2020      
Journal
          Journal of Infectious Diseases      
Study
          P1112      
Impact of Low Birth Weight and Prematurity on Neonatal Raltegravir Pharmacokinetics: Impaact P1097
Citation
Edward P Acosta, Mae P Cababasay, Jiajia Wang, Stephen A Spector, Anne Chain, Elizabeth Smith, Hedy Teppler, Rohan Hazra, Kat Calabrese, Bobbie Graham, Stephanie Popson, Yvonne Bryson, Mark Mirochnick, International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) P1097 Study Team, Diana F Clarke, Jos Lommerse. Impact of Low Birth Weight and Prematurity on Neonatal Raltegravir Pharmacokinetics: Impaact P1097. Journal of Acquired Immune Deficiency Syndromes. 2020. 85: 626-634. PMID: 32925360Year
          2020      
Journal
          Journal of Acquired Immune Deficiency Syndromes      
Study
          P1097      
Pregnancy associates with alterations to the host and microbial proteome in vaginal mucosa
Citation
Trisha Vera, Lani Kotyrba, Laura Noel-Romas, Kenzie Birse, Sarah Mutch, Fan Li, David Lee, Stuart McCorrister, Garrett Westmacott, Grace Aldrovandi, Adam Burgner, Christina Zuend, Nicole Tobin. Pregnancy associates with alterations to the host and microbial proteome in vaginal mucosa. American Journal of Reproductive Immunology. 2020. 83: e13235. PMID: 32196803Year
          2020      
Journal
          American Journal of Reproductive Immunology      
Pharmacokinetic Enhancement of HIV Antiretroviral Therapy During Pregnancy
Citation
Brookie M Best, Mark Mirochnick, Jeremiah D Momper, Engie Salama, Ahizechukwu C Eke. Pharmacokinetic Enhancement of HIV Antiretroviral Therapy During Pregnancy. Journal of Clinical Pharmacology. 2020. 60: 1537-1550. PMID: 32798276Year
          2020      
Journal
          Journal of Clinical Pharmacology      
Study
          P1026S      
Darunavir Pharmacokinetics With an Increased Dose During Pregnancy
Citation
Jiajia Wang, Regis Kreitchmann, David E Shapiro, Elizabeth Smith, Nahida Chakhtoura, Edmund V Capparelli, Mark Mirochnick, Brookie M Best, IMPAACT P1026s Protocol Team, Ahizechukwu C Eke, Alice M Stek. Darunavir Pharmacokinetics With an Increased Dose During Pregnancy. Journal of Acquired Immune Deficiency Syndromes. 2020. 83: 373-380. PMID: 31923087Year
          2020      
Journal
          Journal of Acquired Immune Deficiency Syndromes      
Study
          P1026S      
Prediction of Maternal and Fetal Pharmacokinetics of Dolutegravir and Raltegravir Using Physiologically Based Pharmacokinetic Modeling
Citation
Natella Y Rakhmanina, Dionna J Green, Gilbert J Burckart, Tim R Cressey, Mark Mirochnick, Brookie M Best, John N van den Anker, André Dallmann, Xiaomei I Liu, Jeremiah D Momper. Prediction of Maternal and Fetal Pharmacokinetics of Dolutegravir and Raltegravir Using Physiologically Based Pharmacokinetic Modeling. Clinical Pharmacokinetics. 2020. 59: 1433-1450. PMID: 32451908Year
          2020      
Journal
          Clinical Pharmacokinetics      
Study
          P1026S